Collegium Pharmaceutical Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Collegium Pharmaceutical announced granting 50,305 restricted stock units to 34 new non-executive employees as incentives under its 2026 Inducement Plan. The RSUs vest over three years contingent on continued employment and are issued outside the company’s existing equity plan per Nasdaq listing rules. This move aims to attract talent to support Co…